All In Biotech

Drug Trial Radar · NCT01537471

The Effects of Antihistamines on Pre-Pulse Inhibition

A Pilot Study of the Effects of Meclizine on Pre-Pulse Inhibition

Last checked: Nov 20, 2026Latest source record: Jan 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 117 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

117

Actual

Start

Jan 2012

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Wallace H. Coulter Foundation
First posted
Feb 23, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Single group
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for things like allergies, sleep problems, or the common cold.

Conditions

  • Healthy

Interventions

  • PlaceboDrug

    Placebo

  • MeclizineDrug

    Meclizine 12.5 mg

  • MeclizineDrug

    Meclizine 25 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in PPITime frame: Screening Day 1, Days 2-4

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke University Medical Center

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.